Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994-2003

Int J Tuberc Lung Dis. 2005 Mar;9(3):333-8.

Abstract

Setting: A local tuberculosis control program.

Objective: To examine treatment completion rates of patients with Mycobacterium bovis disease and compare them with those of patients with M. tuberculosis disease.

Design: Retrospective review of data from a tuberculosis surveillance computer database.

Results: Data from 167 M. bovis patients and 928 M. tuberculosis patients were examined. Rates of treatment completion were not significantly different (78% vs. 82%, chi2 = 1.60, P = 0.174), although death was more frequent among M. bovis patients (15% vs. 7%). The median time to treatment completion was 94 days longer for M. bovis patients.

Conclusion: Overall, treatment completion rates of M. bovis and M. tuberculosis patients were comparable, although the death rate was higher for M. bovis patients. The latter finding may be related to a particularly high death rate among HIV-infected M. bovis patients. Therapy duration was longer for M. bovis patients, probably because resistance to pyrazinamide prevented the use of a short-course (6-month) regimen.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antitubercular Agents / therapeutic use*
  • California / epidemiology
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Mycobacterium bovis / isolation & purification*
  • Mycobacterium tuberculosis / isolation & purification
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome
  • Tuberculosis / drug therapy*
  • Tuberculosis / microbiology
  • Tuberculosis / mortality

Substances

  • Antitubercular Agents